GlassScriptPhysician profile
Ashley Oliver Bufe
NPI 1588824155
$1,126.22
in general payments reported to CMS, 2019-2025
15 companies · $53.63 in 2025
The $53.63 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $51.08 · 2021: $25.14 · 2022: $694 · 2023: $19.23 · 2024: $104 · 2025: $53.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $558.16 | 2022 | |
| Tris Pharma INC | $92.08 | 2019-2021 | |
| Pfizer INC. | $68.07 | 2019-2023 | |
| Kaleo, INC. | $67.81 | 2019-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $60.54 | 2021-2024 | Vaxelis, Gardasil 9, Gardasil |
| Cranial Technologies, INC | $43.19 | 2019-2020 | |
| Sanofi Pasteur INC. | $42.06 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $40.83 | 2022 | |
| Sanofi-Aventis U.S. LLC | $33.01 | 2024-2025 | |
| Glaxosmithkline, LLC. | $31.52 | 2019-2022 | |
| Biofire Diagnostics, LLC | $21.78 | 2019 | |
| Seqirus USA INC | $20.33 | 2025 | Flucelvax |
| Alk-Abello, INC | $18.02 | 2025 | Neffy |
| Shire North American Group INC | $15.03 | 2019 | |
| Neos Therapeutics, LP | $13.79 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Bufe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.